Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
June 30, 2019
1.
Accounting Polic
ies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which we believe are necessary to present fairly the financial position, results of operations and cash flows. All significant intercompany accounts and transactions have been eliminated. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2018, filed March 29, 2019 with the Securities and Exchange Commission.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Reclassifications
To conform to the current year presentation, certain previously reported 2018 amounts have been reclassified.
Inventories
Inventories are valued at the lower of cost or market and are accounted for on a first-in, first-out basis. Effective January 1, 2019, finished goods inventories primarily consist of purchased products held for resale. Prior to 2019, finished goods inventories were primarily comprised of internally manufactured products consisting of the costs associated with raw materials, labor, and overhead. On a periodic basis we review our inventory levels, as compared to future demand requirements and the shelf life of the various products. Based on this review, we record inventory write-downs when necessary.
Sales aids and promotional materials inventories represent distributor kits, product brochures, and other sales and business development materials which are held for sale to distributors. Cost of the sales aids and promotional materials held for sale are capitalized as inventories and subsequently recorded to costs of goods sold upon recognition of revenue when sold to distributors. All other advertising and promotional costs are expensed when incurred.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
1.
Accounting Policies (continued)
Variable Interest Entities (VIE) - Unconsolidated
Effective January 1, 2019, we have a financial interest in Nutracom LLC (Nutracom). If we are the primary beneficiary of a VIE, we are required to consolidate the VIE in our consolidated financial statements. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our VIE evaluation requires significant assumptions and judgments.
We do not have the power to direct the significant activities of Nutracom, primarily because we do not have governance rights. We also do not participate in the annual profits or losses of Nutracom. Therefore, we do not consolidate the financial results of Nutracom in our consolidated financial statements. We account for our financial interest in Nutracom as an equity investment measured at cost minus impairment, if any. A cost method equity investment is subject to periodic impairment review using the other-than-temporary impairment model, which considers the severity and duration of a decline in fair value below cost and our ability and intent to hold the investment for a sufficient period of time to allow for recovery.
See Note 2 and Note 3 for further information on our financial relationship with Nutracom.
Concentrations of Risk
Effective January 1, 2019, we have entered into outsourcing agreements with Nutracom to manufacture our nutritional and dietary supplements and for warehousing and fulfillment services for the U.S. distribution of our products. Nutracom has also issued promissory notes to us for the acquisition of our manufacturing and fulfillment operations. Any inability of Nutracom to deliver these contracted services or to repay the promissory notes could adversely impact our future operating results. See Note 2 and Note 3 for further discussion of our relationship with Nutracom.
New Accounting Pronouncements – Not Yet Adopted
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updated (“ASU”) No. 2016-13,
Credit Losses
(Topic
326): Measurement of Credit Losses on Financial Instruments
which requires entities to use a current lifetime expected credit loss methodology to measure impairments of certain financial assets. Using this methodology may result in earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of having been incurred. There are other provisions within the standard that affect how impairments of other financial assets may be recorded and presented, and that expand disclosures. This standard will be effective for our interim and annual financial periods beginning January 1, 2020, with early adoption permitted. Adoption of this standard must be applied on a modified retrospective basis. We are evaluating the potential impact of this standard on our consolidated financial statements and related disclosures.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
1.
Accounting Policies (continued)
New Accounting Pronouncements – Adopted January 1, 2019
Lessee Accounting
On January 1, 2019, we adopted ASU No. 2016-02,
Leases (Topic 842)
(including subsequent issued lease-related ASU’s), and applied the new lease accounting standard to all lessee operating leases using the prospective transition method. Under this method, prior financial reporting periods are not restated. The adoption of the new lease accounting standard resulted in the recording of assets and obligations of our operating leases of approximately $451,000 and $457,000, respectively, on our consolidated balance sheets. Certain amounts previously recorded for prepaid and accrued rent associated with historical operating leases were reclassified to the newly captioned Operating lease right-to-use assets.
At adoption, we used the new lease accounting standard’s package of practical expedients permitted under the transition guidance that allowed us to not reassess: (a) whether any expired or existing contracts are or contain leases, (b) lease classification for any expired or existing leases, and (c) initial direct costs for any expired or existing leases. We also used the lease standard’s practical expedient that allows lessees to treat the lease and implicit non-lease components of our leases as a single lease component and we do not record on the balance sheet leases with an initial term of twelve months or less. Fixed lease expense on all of our operating leases is recognized on a straight-line basis over the contractual lease term, including our estimate of any renewal or early termination lease terms. Operating lease expense is presented within Selling, General and Administrative expense in our operating results.
Operating lease liabilities and related operating lease right-to-use assets are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When leases do not provide an implicit discount rate, we use a country specific incremental borrowing rate based upon the lease term.
See Note 7 for additional lease disclosures.
Less
or
Accounting
– Other Revenue
Other revenue consists of revenue derived from our leasing a portion of our headquarters building to Nutracom, LLC (Nutracom). We recognize lessor rent revenue on a straight-line basis over the term of the lease. As part of this straight-line methodology, the cumulative rental billings may be greater or less than the financial period’s recognized revenue; such timing differences are recognized on the balance sheet as an accrued other liability or an unbilled rent revenue receivable.
Also included in other revenue are billings to the tenant for its share of the facility’s common area costs such as real estate taxes, maintenance, and utilities. These same common area costs plus the tenant’s share of the facilities’ depreciation are recorded as cost of goods sold.
See Note 2 and Note 3 for further information on our financial relationship with Nutracom. See Note 7 for further information on our leases.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
1.
Accounting Policies (continued)
Going Concern
We have incurred operating losses, declining net sales, and negative net cash flows over our most recent five years. Our management estimates that these unfavorable trends are more likely than not to continue for the foreseeable future, and as a result, we will require additional financial support to fund our operations and execute our business plan. As of June 30, 2019, we had $1,918,721 in cash and cash equivalents which may not be sufficient to fund our planned operations through one year subsequent to the date of the issuance of these condensed financial statements, and accordingly, there is substantial doubt about our ability to continue as a going concern. The analysis used to determine our ability to continue as a going concern does not include cash sources outside of our direct control that our management expects to be available within the next twelve months.
We may not be able to obtain sufficient additional funding through monetizing certain of our existing assets, sourcing additional borrowings, and issuing additional equity, or any other means, and if we are able to do so, these available sources of funds may not be on satisfactory terms. Our ability to raise additional capital in the equity markets, should we choose to do so, is dependent on a number of factors, including, but not limited to, the market demand for our common stock, which itself is subject to a number of business risks and uncertainties, as well as the uncertainty that we would be able to raise such additional capital at a price or on terms that we believe are favorable.
We have taken several steps in 2019 which we believe will result in improvement to our financial position, operating results, and cash flows. We have borrowed $500,000 of our available $750,000 revolving line of credit balance. In addition, our lender has agreed to extend the available $750,000 revolving line of credit agreement to April 28, 2020.
As detailed in Note 2 of these condensed consolidated financial statements, on January 1, 2019, we sold the assets previously used by us in our manufacturing operations to Nutracom LLC (Nutracom). We financed the assets purchased by Nutracom from us under payment terms scheduled to provide incoming funds to us of $100,000 or more per year. We have also entered into an agreement for Nutracom to lease a significant portion of our headquarters building. Our management believes that these transactions with Nutracom will be favorable to our financial position, operating results, and cash flows; however, there are risks and uncertainties which arise from these Nutracom transactions and their impact to our operations.
Should the aforementioned changes to our operations not provide sufficient cash flow improvement or should we be unable to obtain sufficient additional capital or borrowings, we may have to engage in any or all of the following activities: (i) seek to monetize our headquarters building via traditional bank lending or a sale and leaseback-type transaction; (ii) monetizing the note receivable from a distributor; (iii) modify our distributor promotions, incentives, and other activities; (iv) cease operations in certain geographic regions, and (v) reduce employee compensation and benefits.
These actions may have a material adverse impact on our ability to achieve certain of our planned objectives. Even if we are able to source additional funding, we may be forced to significantly reduce our operations or shut down our operations if our business operating performance does not improve. These condensed consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary in the event we can no longer continue as a going concern.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
2. Sale of Manufacturing Operations’ Assets
On January 1, 2019, we entered into a Purchase Agreement with Nutracom, LLC (Nutracom) pursuant to which Nutracom purchased the following assets previously used by us in our manufacturing operations:
|
●
|
Inventories (sold at cost of $1.56 million) and,
|
|
●
|
Machinery and other equipment with a net book value of $565,000 (sold for $1 million; gain on disposal of approximately $435,000).
|
Nutracom was formed by our manufacturing operations management which included former officers of the Company. Employees of our manufacturing operations were offered employment by Nutracom.
Prior to its approval of the transaction, our Board of Directors formed a special committee consisting of the Board’s independent directors to review the transaction. To assist in its review, the special committee engaged a qualified third-party expert to render a fairness opinion on the transaction.
Concurrently with the execution of the Purchase Agreement, we entered into several agreements with Nutracom including a product supply agreement for a term of seven years, a fulfillment agreement, and a facility lease agreement whereby Nutracom will lease manufacturing, warehouse, and certain office space of our headquarters building from us for a term of seven years, with a Nutracom option for an additional five-year term. Annual lease amounts range from $193,000 to $410,000 over the seven-year term.
Nutracom provided the following consideration to us for the manufacturing operations and related identified assets and agreements:
|
●
|
$1 million secured promissory note, seven year term, fixed interest rate of 5.5%, principal and interest payable monthly. (See June 1, 2019 note modification within this Note 2).
|
|
●
|
$764,344 unsecured promissory note, seven year term, fixed interest rate of 7.0%, interest only payable for the first two years with monthly payment of principal and interest thereafter under a ten-year amortization schedule. The face value of the unsecured note includes the first year’s rent due under the facility lease agreement.
|
|
●
|
Nutracom management transferred to us its ownership of 99,200 shares of our common stock valued at $540,144.
|
|
●
|
Nutracom issued to us a non-voting Class B 15% equity membership interest in Nutracom, LLC. The Class B interest does not share in any profits or losses from operations of Nutracom. As defined within the Nutracom Operating Agreement, upon any merger, consolidation, disposition, or liquidation of Nutracom, the Class B equity membership interest converts to a Class A equity membership interest.
|
|
●
|
Commencing January 1, 2020, our Class B interest will be entitled to receive a percentage, (ranging from 1.0% to 1.25%) of Nutracom’s annual revenues (excluding Nutracom’s revenues from sales to us).
|
Our non-voting Class B 15% equity membership interest in Nutracom was valued by the aforementioned third-party expert at $505,000. As our non-voting membership interest does not participate in the management of Nutracom, nor do we share in any Nutracom operating profits or losses, we are accounting for our Nutracom equity investment under the cost method.
At December 31, 2018, we presented inventories and machinery and other equipment sold to Nutracom as a current asset under the caption of “Assets held for sale” in the accompanying condensed consolidated balance sheets. We have accounted for the Nutracom aforementioned transactions in our first quarter 2019 financial results.
Promissory Note Modification – June 1, 2019
On June 1, 2019, we entered into an Agreement with Nutracom to modify the Secured Promissory Note originally issued to us by Nutracom on January 1, 2019, as follows:
|
●
|
Effective June 1, 2019, the outstanding balance of the Secured Promissory Note was reduced by $500,000 to $460,583 with a corresponding reduction of $500,000 to our outstanding vendor obligation due Nutracom under our ongoing product supply agreement.
|
|
●
|
The $460,583 remaining Secured Promissory Note was exchanged with Nutracom for a newly issued June 1, 2019 Nutracom unsecured promissory note for the same amount under the following terms: fixed interest rate of 6.0% with interest only payable monthly through December 2020. Beginning January 1, 2021, principal and interest of $8,904 will be payable monthly for 60 months.
|
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
3. Related Parties
The following summarizes our related party activities with Nutracom and a significant distributor of the Company.
|
|
June 30
|
|
|
December 31
|
|
Assets and liabilities - related parties
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Notes & accounts receivables and deposits - current
|
|
|
|
|
|
|
|
|
Deposits with Nutracom for inventory
|
|
$
|
827,356
|
|
|
$
|
-
|
|
Notes receivable - distributor
|
|
|
126,778
|
|
|
|
123,040
|
|
Other miscellaneous receivables
|
|
|
72,992
|
|
|
|
28,182
|
|
|
|
$
|
1,027,126
|
|
|
$
|
151,222
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes & accounts receivables - non-current
|
|
|
|
|
|
|
|
|
Notes receivable - distributor
|
|
$
|
1,217,735
|
|
|
$
|
1,282,072
|
|
Notes receivable - Nutracom unsecured DTD 1/1/2019
|
|
|
764,344
|
|
|
|
-
|
|
Notes receivable - Nutracom unsecured DTD 6/1/2019
|
|
|
460,583
|
|
|
|
-
|
|
Unbilled receivables: Straight line rent revenue greater than rental billings
|
|
|
47,866
|
|
|
|
-
|
|
|
|
$
|
2,490,528
|
|
|
$
|
1,282,072
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity investment in Nutracom
|
|
$
|
505,000
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Liability captions with Nutracom balances included therein
|
|
|
|
|
|
|
|
|
Trade accounts payable and other accrued expenses
|
|
$
|
62,849
|
|
|
|
-
|
|
Deferred rent liability
|
|
|
125,000
|
|
|
|
-
|
|
The following table presents scheduled principal payments to be received on the distributor and Nutracom promissory notes receivable:
Remainder of 2019
|
|
$
|
62,441
|
|
2020
|
|
|
130,629
|
|
2021
|
|
|
274,844
|
|
2022
|
|
|
292,377
|
|
2023
|
|
|
311,033
|
|
Thereafter
|
|
|
1,498,116
|
|
|
|
$
|
2,569,440
|
|
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
3. Related Parties (continued)
|
|
Six months ended June 30
|
|
Revenue and expense - related parties
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Other revenue
|
|
$
|
332,657
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expense:
|
|
|
|
|
|
|
|
|
Fullfillment & professional fees
|
|
|
305,910
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Interest income on promissory notes
|
|
|
92,668
|
|
|
|
44,778
|
|
Gain on sale of fixed assets
|
|
|
434,549
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Finished goods inventory purchased from Nutracom
|
|
$
|
2,763,000
|
|
|
|
-
|
|
At June 30, 2019, we had $1.4 million in commitments (net of deposits) to purchase finished goods inventory from Nutracom.
S
upplementary Disclosure of Cash Flows Information
:
We incurred the following noncash investing and financing transactions on January 1, 2019 and June 1, 2019 relating to our transactions with Nutracom:
|
|
2019
|
|
|
|
|
|
|
January 1, 2019
|
|
|
|
|
Sale of fixed assets
|
|
$
|
1,000,000
|
|
Sale of inventories
|
|
|
1,559,488
|
|
First year building rental received in advance
|
|
|
250,000
|
|
Acquire company common stock for treasury
|
|
|
540,144
|
|
Acquire equity investment in Nutracom
|
|
|
505,000
|
|
Secured promissory note received
|
|
|
1,000,000
|
|
Unsecured promissory note received
|
|
|
764,344
|
|
|
|
|
|
|
June 1, 2019
|
|
|
|
|
Secured promissory note receivable balance decreased; applied as reduction to outstanding trade accounts payable
|
|
|
500,000
|
|
Unsecured promissory note received in exchange for remaining secured promissory note balance and other considerations
|
|
|
460,583
|
|
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
4. Basic and Diluted Earnings (Loss) per Share
Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock.
The following table sets forth the computation of basic and diluted earnings (loss) per share:
|
|
Three months ended
|
|
|
Six months ended
|
|
|
|
June 30
|
|
|
June 30
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(388,105
|
)
|
|
$
|
(977,954
|
)
|
|
$
|
235,539
|
|
|
$
|
(1,216,259
|
)
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings (loss) per share – weighted average shares
|
|
|
1,746,000
|
|
|
|
1,845,000
|
|
|
|
1,746,000
|
|
|
|
1,845,000
|
|
Dilutive effect of employee stock options and other warrants
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Denominator for diluted earnings (loss) per share – adjusted weighted average shares
|
|
|
1,746,000
|
|
|
|
1,845,000
|
|
|
|
1,746,000
|
|
|
|
1,845,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share
|
|
$
|
(0.22
|
)
|
|
$
|
(0.53
|
)
|
|
$
|
0.13
|
|
|
$
|
(0.66
|
)
|
Diluted earnings (loss) per share
|
|
$
|
(0.22
|
)
|
|
$
|
(0.53
|
)
|
|
$
|
0.13
|
|
|
$
|
(0.66
|
)
|
Options and warrants to purchase 85,203 shares of common stock for the three months and six months ended June 30, 2019, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable. Options and warrants to purchase 120,242 shares of common stock for the three months and six months ended June 30, 2018, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
5
.
Fair Value of Financial Instruments
Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels:
Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active.
Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.
The carrying amount and fair value of financial instruments were approximately as follows:
|
|
Carrying
|
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description
|
|
Amount
|
|
|
Value
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revolving line of credit
|
|
$
|
500,000
|
|
|
$
|
500,000
|
|
|
|
-
|
|
|
$
|
500,000
|
|
|
|
-
|
|
Note receivable - distributor
|
|
|
1,344,513
|
|
|
|
1,474,000
|
|
|
|
-
|
|
|
|
1,474,000
|
|
|
|
-
|
|
Notes receivable - Nutracom
|
|
|
1,224,927
|
|
|
|
1,224,927
|
|
|
|
-
|
|
|
|
1,224,927
|
|
|
|
-
|
|
Marketable securities
|
|
|
408,000
|
|
|
|
408,000
|
|
|
$
|
408,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note receivable - distributor
|
|
$
|
1,405,112
|
|
|
$
|
1,529,000
|
|
|
|
-
|
|
|
$
|
1,529,000
|
|
|
|
-
|
|
Marketable securities
|
|
|
339,000
|
|
|
|
339,000
|
|
|
$
|
339,000
|
|
|
|
-
|
|
|
|
-
|
|
Revolving line of credit
: The fair value of our revolver loan approximates carrying value as this loan was amended within the past year and has a variable market-based interest rate that resets every thirty days.
Note receivable
- distributor
: The note receivable - distributor is a variable rate residential mortgage-based financial instrument. An average of published interest rate quotes for a fifteen-year residential jumbo mortgage, a comparable financial instrument, was used to estimate fair value of this note receivable under a discounted cash flow model.
Note
s
receivable
- Nutracom
: The fair value of the notes receivable – Nutracom balance approximates carrying value as these notes were received at fair value within the current fiscal year.
Marketable securities
: The assets (trading securities) of our Supplemental Executive Retirement Plan are recorded at fair value on a recurring basis, and are presented within Other Assets in the consolidated balance sheets.
The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of the respective balances.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
6
. Debt
On September 30, 2015, we entered into a series of lending agreements with our primary lender which included agreements for a term loan and a revolving credit facility. The term loan was repaid in 2018 and the revolver has been periodically amended and extended.
Effective with a September 11, 2018 amendment, the revolving line of credit’s maximum borrowing amount was $750,000. The revolver’s maturity date was April 29, 2019 and the revolver’s interest rate was based on the 30-day LIBOR plus 2.25%. As of December 31, 2018, there were no outstanding borrowings on the revolving line of credit. In January 2019, the Company borrowed $500,000 under its revolving line of credit.
Effective with a March 25, 2019 amendment, the revolving line of credit’s maturity date was extended to April 28, 2020 and the interest rate was revised to the 30-day LIBOR plus 3.00%. As amended, the revolver’s maximum borrowing amount remains $750,000. At June 30, 2019, outstanding borrowings under the revolving line of credit were $500,000 at an interest rate of 5.48%.
Borrowings under the lending agreement continue to be secured by all of our tangible and intangible assets and by a mortgage on the real estate of our headquarters facility. At June 30, 2019, the Company was in compliance with its loan covenant requirements.
7. Leases
Less
ee
The Company leases certain office facilities, storage, and equipment. These leases have varying terms, are generally one to five years in length, and certain real estate leases have options to extend or early terminate. Several of our operating leases are subject to annual changes in the Consumer Price or similar indexes (CPI). The changes to the lease payment due to CPI changes are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.
The following table represents the maturity of our operating lease liabilities as of June 30, 2019:
Remainder of 2019
|
|
$
|
118,728
|
|
2020
|
|
|
185,980
|
|
2021
|
|
|
19,588
|
|
2022
|
|
|
14,781
|
|
2023
|
|
|
5,557
|
|
Thereafter
|
|
|
-
|
|
Total operating lease payments
|
|
|
344,634
|
|
Less: imputed interest
|
|
|
(14,250
|
)
|
Total operating lease liabilities
|
|
$
|
330,384
|
|
Operating lease expense:
|
|
Three months ended
|
|
|
Six months ended
|
|
|
|
June 30, 2019
|
|
|
June 30, 2019
|
|
Fixed
|
|
$
|
60,269
|
|
|
$
|
124,972
|
|
Variable
|
|
|
4,023
|
|
|
|
9,472
|
|
Short-term
|
|
|
5,265
|
|
|
|
15,036
|
|
Total
|
|
$
|
69,557
|
|
|
$
|
149,480
|
|
As of June 30, 2019, our operating leases have a weighted-average remaining lease term of 1.8 years and a weighted-average discount rate of 5.2%. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $134,600 for the six months ended June 30, 2019.
Less
or
– Other Revenue
Other revenue consists of revenue derived from our leasing a portion of our headquarters building to Nutracom, LLC (Nutracom) effective January 1, 2019. The leased space, encompassing manufacturing, warehouse, and certain office space, is for a term of seven years, with a tenant option for an additional five-year term. Annual lease amounts range from $193,000 to $410,000 over the seven-year term.
We recognize lessor rent revenue on a straight-line basis over the term of the lease. As part of this straight-line methodology, the cumulative rental billings may be greater or less than the financial period’s recognized revenue; such timing differences are recognized on the balance sheet as an accrued other liability or an unbilled rent revenue receivable.
Also included in other revenue are billings to the tenant for its share of the facility’s common area costs such as real estate taxes, maintenance, and utilities. These same common area costs plus the tenant’s share of the facilities’ depreciation are recorded as cost of goods sold.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
7. Leases (continued)
Less
or
– Other Revenue (continued)
The following table details lessor’s estimated remaining straight-line rent revenue over the seven-year lease term as compared with fixed rent amounts under the lease agreement.
|
|
Estimated
|
|
|
|
|
|
|
|
Straight-line
|
|
|
Lease Agreement
|
|
|
|
Rent Revenue
|
|
|
Fixed Rent
|
|
|
|
|
|
|
|
|
|
|
Remainder of 2019
|
|
$
|
172,866
|
|
|
$
|
125,000
|
|
2020
|
|
|
345,732
|
|
|
|
192,900
|
|
2021
|
|
|
345,732
|
|
|
|
385,800
|
|
2022
|
|
|
345,732
|
|
|
|
385,800
|
|
2023
|
|
|
345,732
|
|
|
|
385,800
|
|
Thereafter
|
|
|
691,465
|
|
|
|
819,825
|
|
Total
|
|
$
|
2,247,259
|
|
|
$
|
2,295,125
|
|
8
. Income Taxes
During the fiscal years of 2016 through 2018, we determined that it was more likely than not that U.S. federal and various state net operating losses generated in those years will not be realized based on projections of future U.S. taxable income, estimated reversals of existing taxable timing differences, and other considerations.
In prior years, we recorded a valuation allowance on all of our domestic and foreign deferred tax assets. The effective income tax rate was 32.0% and (3.4)% for the year to date periods ended June 30, 2019 and 2018, respectively. The income tax provision amounts primarily represent estimated income taxes for one of the Company’s foreign subsidiaries and certain U.S. states.
One of our foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 plus interest at 20% per annum) in value-added tax (VAT) and withholding tax for the years 2004 through 2006. In consultation with our legal counsel, we believe that there are strong legal grounds that we should not be liable to pay the majority of the alleged tax deficiencies. In 2011, we made good faith deposits of approximately $173,000 to the local tax authority under the tax agency’s administrative judicial resolution process.
As of December 31, 2018, our estimated reserve (net of deposits) for this matter was approximately $172,500 and remains unchanged in 2019. In May 2018, we received a formal notice of denial of one of our appeals under the tax agency’s administrative judicial resolution process; however, we continue to pursue other available legal processes as we continue to maintain our position that we are not liable for the majority of the alleged tax deficiencies.
Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)
9
.
Revenue Recognition
We recognize revenue from product sales under a five step process with our independent distributors (including customers) when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. Product sales revenue (principally nutritional and dietary supplements) and commission expenses are recorded when control is transferred to the independent distributors, which occurs at the time of shipment. Generally, net sales reflect product sales less the distributor discount of 20 percent to 40 percent of the suggested retail price. We present distributor royalty and commission expense as an operating expense, rather than a reduction to net sales, as these payments are not made to the purchasing distributor. At point of sale, we receive payment by credit card, personal check, or guaranteed funds for contracts from independent distributors and make related commission payments in the following month.
We recognize the performance obligation for membership fees-type revenue over the membership term of generally twelve months. We receive payment for membership fees revenue at the beginning of the membership term and recognize membership fees revenue on a straight-line basis in correlation with the completion of our performance obligation under the membership term. Our remaining unearned membership fees obligation is reported as deferred revenue liability.
We record freight income as a component of net sales and record freight costs as a component of cost of goods sold. Total sales do not include sales tax as we consider ourselves a pass-through conduit for collecting and remitting applicable sales taxes.
Other revenue is defined in Note 7 - Leases.
Actual and estimated sales returns are classified as a reduction of net sales. We estimate and accrue a reserve for product returns based on our return policy and historical experience. Our product returns policy allows for distributors to return product only upon termination of his or her distributorship. Allowable returns are limited to saleable product which was purchased within twelve months of the termination for a refund of 100% of the original purchase price less any distributor royalties and commissions received relating to the original purchase of the returned products. For the year to date periods ending June 30, 2019 and 2018, total returns as a percent of net sales were approximately 0.07% and 0.26%, respectively.
We classify our net sales into two categories of sales products, plus freight income, and other revenue:
|
|
Three months ended June 30
|
|
|
Six months ended June 30
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
Net sales by product category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nutritional and dietary supplements
|
|
$
|
7,284,897
|
|
|
$
|
7,606,674
|
|
|
$
|
15,782,247
|
|
|
$
|
16,676,031
|
|
Sales aids, membership fees, and other
|
|
|
318,144
|
|
|
|
313,922
|
|
|
|
631,791
|
|
|
|
635,946
|
|
Freight income
|
|
|
479,881
|
|
|
|
539,145
|
|
|
|
999,822
|
|
|
|
1,151,003
|
|
Other revenue
|
|
|
174,091
|
|
|
|
-
|
|
|
|
332,657
|
|
|
|
-
|
|
Total net sales
|
|
$
|
8,257,013
|
|
|
$
|
8,459,741
|
|
|
$
|
17,746,517
|
|
|
$
|
18,462,980
|
|
We operate in one reportable segment, a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. These operating units are based on geographic regions, as follows:
|
|
Three months ended June 30
|
|
|
Six months ended June 30
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
Net sales by geographic region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
5,904,605
|
|
|
$
|
6,336,387
|
|
|
$
|
13,016,378
|
|
|
$
|
14,006,448
|
|
Australia/New Zealand
|
|
|
132,330
|
|
|
|
177,536
|
|
|
|
309,377
|
|
|
|
409,464
|
|
Canada
|
|
|
140,029
|
|
|
|
161,557
|
|
|
|
339,428
|
|
|
|
403,677
|
|
Mexico
|
|
|
152,569
|
|
|
|
112,411
|
|
|
|
288,595
|
|
|
|
219,782
|
|
Europe
(1)
|
|
|
756,264
|
|
|
|
1,030,546
|
|
|
|
1,694,933
|
|
|
|
2,195,430
|
|
Asia
(2)
|
|
|
1,171,216
|
|
|
|
641,304
|
|
|
|
2,097,806
|
|
|
|
1,228,179
|
|
Total net sales
|
|
$
|
8,257,013
|
|
|
$
|
8,459,741
|
|
|
$
|
17,746,517
|
|
|
$
|
18,462,980
|
|
(1)
|
Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.
|
(2)
|
Asia consists of Philippines, Malaysia, and Singapore.
|
FORWARD-LOOKING STATEMENTS
This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this annual report to conform such statements to actual results or to changes in our opinions or expectations.
Item No. 2 - Management
’
s Discussion and Analysis of Financial
Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this
Quarterly
Report on Form 10-
Q
. The following discussion and analysis discusses the financial condition and results of our operations on a consolidated basis, unless otherwise indicated.
Overview
We are a developer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. We sell our products through an international network marketing system utilizing independent distributors. Sales in the United States represented approximately 73.4% of worldwide net sales for the six months ended June 30, 2019 and 75.9% of worldwide net sales for the six months ended June 30, 2018. Our international operations currently generate sales through distributor networks with facilities in Australia, Canada, Malaysia, Mexico, the Philippines, and the United Kingdom. We also operate in Ireland, France, Germany, Austria and the Netherlands from our United Kingdom distribution center, and in New Zealand from our Australia office.
We derive our revenues principally through product sales made by our global independent distributor base, which, as of June 30, 2019, consisted of approximately 32,870 distributors and preferred customers. Our sales can be affected by several factors, including our ability to attract new distributors and retain our existing distributor base, our ability to properly train and motivate our distributor base and our ability to develop new products and successfully maintain our current product line.
All of our sales to distributors outside the United States are made in the respective local currency; therefore, our earnings and cash flows are subject to fluctuations due to changes in foreign currency rates as compared to the U.S. dollar. As a result, exchange rate fluctuations may have an effect on sales and gross margins. U.S. generally accepted accounting practices require that our results from operations be converted to U.S. dollars for reporting purposes. Consequently, our reported earnings may be significantly affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. Products purchased by our foreign subsidiaries are acquired in U.S. dollars and sold in local country currency. From time to time, we enter into foreign exchange forward contracts to mitigate our foreign currency exchange risk.
Components of Net Sales and Expense
Product sales represent the actual product purchase price typically paid by our distributors, after giving effect to distributor allowances, which can range from 20% to 40% of suggested retail price, depending on the rank of a particular distributor. Freight income represents the amounts billed to distributors for shipping costs. We record net sales and the related commission expense when the merchandise is shipped. Other revenue included in net sales now includes the leasing revenue, plus common area expense billings, on the lease of the manufacturing portion of our building to Nutracom, LLC (“Nutracom”) as of January 1, 2019 after the adoption of ASU 2016-02.
Our primary expenses include cost of products sold, distributor royalties and commissions and selling, general and administrative expenses.
In 2018, our cost of goods sold primarily consists of expenses related to raw materials, labor, quality control and overhead directly associated with production of our products and sales materials, as well as shipping costs relating to the shipment of products to distributors, and duties and taxes associated with product exports. Cost of goods sold is impacted by the cost of the ingredients used in our products, the cost of shipping distributors’ orders, along with our efficiency in managing the production of our products. For 2019, we no longer manufacture our products; therefore, the costs consist of the purchase price of the products, along with shipping costs, and duties and taxes where applicable. Cost of goods sold also include the costs related to leasing income now included in net sales after the adoption of ASU 2016-02.
Distributor royalties and commissions are monthly payments made to distributors based on products sold in their downline organization. Based on our distributor agreements, these expenses have typically approximated 23% of sales at suggested retail. Wholesale pricing discounts on distributor orders are based on the retail value of the product. Distributor royalties and commissions are paid on an amount referred to as the business value (“BV”), which typically ranges between 80% and 90% of the retail price of each product. Also, we include other sales leadership bonuses, such as Ambassador bonuses, within this caption. Overall, distributor royalties and commissions remain directly related to the level of our sales and should continue at comparable levels as a percentage of net sales going forward.
Selling, general and administrative expenses include the compensation and benefits paid to our employees, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, depreciation and amortization, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits; the amount we decide to invest in distributor training and motivational initiatives; and the cost of regulatory compliance.
Results of Operations
Net Sales.
Overall net sales decreased by 2.4% in the three months ended June 30, 2019 compared to the same period in 2018. During the second quarter of 2019 (“Q2 2019”), sales in the United States decreased by 6.8%, and international sales increased by 10.8% over the prior-year period. International sales, when reported in U.S. dollars, were negatively impacted by a stronger U.S. dollar versus most of the currencies of the markets where we do business. Excluding the impact of currency exchange fluctuation, international sales increased by 13.2%.
The following table summarizes net sales by geographic market for the three months ended June 30, 2019 and 2018.
|
|
Three months ended
June
3
0
,
|
|
|
|
|
|
|
|
|
|
|
20
1
9
|
|
20
1
8
|
|
Change from prior year
|
|
|
Amount
|
|
% of Net
Sales
|
|
Amount
|
|
% of Net
Sales
|
|
Amount
|
|
%
|
|
|
(dollars in thousands)
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
5,905
|
|
|
|
71.5
|
%
|
|
$
|
6,336
|
|
|
|
74.9
|
%
|
|
$
|
(431
|
)
|
|
|
(6.8
|
)%
|
Australia/New Zealand
|
|
|
132
|
|
|
|
1.6
|
|
|
|
178
|
|
|
|
2.1
|
|
|
|
(46
|
)
|
|
|
(25.8
|
)
|
Canada
|
|
|
140
|
|
|
|
1.7
|
|
|
|
162
|
|
|
|
1.9
|
|
|
|
(22
|
)
|
|
|
(13.6
|
)
|
Mexico
|
|
|
153
|
|
|
|
1.8
|
|
|
|
112
|
|
|
|
1.3
|
|
|
|
41
|
|
|
|
36.6
|
|
Europe
|
|
|
756
|
|
|
|
9.2
|
|
|
|
1,031
|
|
|
|
12.2
|
|
|
|
(275
|
)
|
|
|
(26.7
|
)
|
Asia
|
|
|
1,171
|
|
|
|
14.2
|
|
|
|
641
|
|
|
|
7.6
|
|
|
|
530
|
|
|
|
82.7
|
|
Consolidated total
|
|
$
|
8,257
|
|
|
|
100.0
|
%
|
|
$
|
8,460
|
|
|
|
100.0
|
%
|
|
$
|
(203
|
)
|
|
|
(2.4
|
)%
|
The following table summarizes net sales by geographic market for the six months ended June 30, 2019 and 2018.
|
|
Six months ended June 30,
|
|
|
|
|
|
|
|
|
|
|
201
9
|
|
201
8
|
|
Change from prior year
|
|
|
Amount
|
|
% of Net
Sales
|
|
Amount
|
|
% of Net
Sales
|
|
Amount
|
|
%
|
|
|
(dollars in thousands)
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
13,016
|
|
|
|
73.4
|
%
|
|
$
|
14,006
|
|
|
|
75.9
|
%
|
|
$
|
(990
|
)
|
|
|
(7.1
|
)%
|
Australia/New Zealand
|
|
|
309
|
|
|
|
1.7
|
|
|
|
410
|
|
|
|
2.2
|
|
|
|
(101
|
)
|
|
|
(24.6
|
)
|
Canada
|
|
|
340
|
|
|
|
1.9
|
|
|
|
404
|
|
|
|
2.2
|
|
|
|
(64
|
)
|
|
|
(15.8
|
)
|
Mexico
|
|
|
289
|
|
|
|
1.6
|
|
|
|
220
|
|
|
|
1.2
|
|
|
|
69
|
|
|
|
31.4
|
|
Europe
|
|
|
1,695
|
|
|
|
9.6
|
|
|
|
2,195
|
|
|
|
11.9
|
|
|
|
(500
|
)
|
|
|
(22.8
|
)
|
Asia
|
|
|
2,098
|
|
|
|
11.8
|
|
|
|
1,228
|
|
|
|
6.6
|
|
|
|
870
|
|
|
|
70.8
|
|
Consolidated total
|
|
$
|
17,747
|
|
|
|
100.0
|
%
|
|
$
|
18,463
|
|
|
|
100.0
|
%
|
|
$
|
(716
|
)
|
|
|
(3.9
|
)%
|
The following table sets forth, as of June 30, 2019 and 2018, the number of our active distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews his or her distributorship during the prior twelve months. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliate groups in their downline organization. We include Preferred Customers as part of our Active Distributor count, and Preferred Customers represent approximately 7,520 and 4,760 of the Active Distributor count as of June 30, 2019 and 2018, respectively.
|
|
June 30, 201
9
|
|
June 30, 201
8
|
|
% Change
|
|
|
Active
Distributors
and Preferred Customers
|
|
Master
Affiliates and
Above
|
|
Active
Distributors
and Preferred Customers
|
|
Master
Affiliates and
Above
|
|
Active
Distributors
and Preferred Customers
|
|
Master
Affiliates and
Above
|
United States
|
|
|
19,290
|
|
|
|
1,980
|
|
|
|
21,060
|
|
|
|
2,270
|
|
|
|
(8.4
|
)%
|
|
|
(12.8
|
)%
|
Australia/New Zealand
|
|
|
910
|
|
|
|
70
|
|
|
|
1,030
|
|
|
|
80
|
|
|
|
(11.7
|
)
|
|
|
(12.5
|
)
|
Canada
|
|
|
530
|
|
|
|
60
|
|
|
|
580
|
|
|
|
80
|
|
|
|
(8.6
|
)
|
|
|
(25.0
|
)
|
Mexico
|
|
|
1,190
|
|
|
|
100
|
|
|
|
780
|
|
|
|
70
|
|
|
|
52.6
|
|
|
|
42.9
|
|
Europe
|
|
|
2,530
|
|
|
|
300
|
|
|
|
3,290
|
|
|
|
380
|
|
|
|
(23.1
|
)
|
|
|
(21.1
|
)
|
Asia
|
|
|
8,420
|
|
|
|
470
|
|
|
|
4,400
|
|
|
|
320
|
|
|
|
91.4
|
|
|
|
46.9
|
|
Consolidated total
|
|
|
32,870
|
|
|
|
2,980
|
|
|
|
31,140
|
|
|
|
3,200
|
|
|
|
5.6
|
%
|
|
|
(6.9
|
)%
|
Use of Non-GAAP Financial Information
Net sales expressed in local currency or net sales adjusted for the impact of foreign currency fluctuation are non-GAAP financial measures. We use these measurements to assess the level of business activity in a foreign market, absent the impact of foreign currency fluctuation relative to the United States dollar, which our local management has no ability to influence. This is a meaningful measurement to management, and we believe this is a useful measurement to provide to shareholders.
The following table provides key statistics related to distributor activity by market and should be read in conjunction with the following discussion. Adjusted results should be considered only in conjunction with results reported according to accounting principles generally accepted in the United States.
Distributor Activity by Market
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International
|
|
|
United States
|
|
AUS/NZ
|
|
Canada
|
|
Mexico
|
|
Europe
|
|
Asia
|
|
-- Total
|
Sales in USD (in 000's):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter ended 6/30/2019
|
|
$
|
5,905
|
|
|
$
|
132
|
|
|
$
|
140
|
|
|
$
|
153
|
|
|
$
|
756
|
|
|
$
|
1,171
|
|
|
$
|
2,352
|
|
Quarter ended 6/30/2018
|
|
$
|
6,336
|
|
|
$
|
178
|
|
|
$
|
162
|
|
|
$
|
112
|
|
|
$
|
1,031
|
|
|
$
|
641
|
|
|
$
|
2,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% change in sales-Q2 2019 vs. Q2 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in USD
|
|
|
(6.8
|
)%
|
|
|
(25.8
|
)%
|
|
|
(13.6
|
)%
|
|
|
36.6
|
%
|
|
|
(26.7
|
)%
|
|
|
82.7
|
%
|
|
|
10.8
|
%
|
due to currency fluctuation
|
|
|
-
|
|
|
|
(5.8
|
)%
|
|
|
(3.2
|
)%
|
|
|
2.1
|
%
|
|
|
(4.3
|
)%
|
|
|
0.9
|
%
|
|
|
(2.4
|
)%
|
Sales in local currency (non-GAAP)
|
|
|
(6.8
|
)%
|
|
|
(20.0
|
)%
|
|
|
(10.4
|
)%
|
|
|
34.5
|
%
|
|
|
(22.4
|
)%
|
|
|
81.8
|
%
|
|
|
13.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of new distributors-Q2 2019
(1)
|
|
|
1,061
|
|
|
|
35
|
|
|
|
22
|
|
|
|
193
|
|
|
|
262
|
|
|
|
1,719
|
|
|
|
2,231
|
|
# of new distributors-Q2 2018
(1)
|
|
|
979
|
|
|
|
37
|
|
|
|
20
|
|
|
|
140
|
|
|
|
373
|
|
|
|
664
|
|
|
|
1,234
|
|
% change
|
|
|
8.4
|
%
|
|
|
(5.4
|
)%
|
|
|
10.0
|
%
|
|
|
37.9
|
%
|
|
|
(29.8
|
)%
|
|
|
158.9
|
%
|
|
|
80.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of new Master Affiliates-Q2 2019
|
|
|
124
|
|
|
|
2
|
|
|
|
2
|
|
|
|
14
|
|
|
|
14
|
|
|
|
118
|
|
|
|
150
|
|
# of new Master Affiliates-Q2 2018
|
|
|
84
|
|
|
|
0
|
|
|
|
3
|
|
|
|
15
|
|
|
|
31
|
|
|
|
27
|
|
|
|
76
|
|
% change
|
|
|
47.6
|
%
|
|
|
N/A
|
|
|
|
(33.3
|
)%
|
|
|
(6.7
|
)%
|
|
|
(54.8
|
)%
|
|
|
337.0
|
%
|
|
|
97.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of Product orders-Q2 2019
|
|
|
24,900
|
|
|
|
916
|
|
|
|
558
|
|
|
|
1,100
|
|
|
|
2,715
|
|
|
|
10,512
|
|
|
|
15,801
|
|
# of Product orders-Q2 2018
|
|
|
26,092
|
|
|
|
1,093
|
|
|
|
604
|
|
|
|
887
|
|
|
|
3,347
|
|
|
|
7,113
|
|
|
|
13,044
|
|
% change
|
|
|
(4.6
|
)%
|
|
|
(16.2
|
)%
|
|
|
(7.6
|
)%
|
|
|
24.0
|
%
|
|
|
(18.9
|
)%
|
|
|
47.8
|
%
|
|
|
21.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International
|
|
|
United States
|
|
AUS/NZ
|
|
Canada
|
|
Mexico
|
|
Europe
|
|
Asia
|
|
-- Total
|
Sales in USD (in 000's):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YTD ended 6/30/2019
|
|
$
|
13,016
|
|
|
$
|
309
|
|
|
$
|
340
|
|
|
$
|
289
|
|
|
$
|
1,695
|
|
|
$
|
2,098
|
|
|
$
|
4,731
|
|
YTD ended 6/30/2018
|
|
$
|
14,006
|
|
|
$
|
410
|
|
|
$
|
404
|
|
|
$
|
220
|
|
|
$
|
2,195
|
|
|
$
|
1,228
|
|
|
$
|
4,457
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% change in sales-YTD 2019 vs. YTD 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in USD
|
|
|
(7.1
|
)%
|
|
|
(24.6
|
)%
|
|
|
(15.8
|
)%
|
|
|
31.4
|
%
|
|
|
(22.8
|
)%
|
|
|
70.8
|
%
|
|
|
6.1
|
%
|
due to currency fluctuation
|
|
|
-
|
|
|
|
(6.7
|
)%
|
|
|
(3.6
|
)%
|
|
|
(0.8
|
)%
|
|
|
(4.9
|
)%
|
|
|
(1.0
|
)%
|
|
|
(3.7
|
)%
|
Sales in local currency (non-GAAP)
|
|
|
(7.1
|
)%
|
|
|
(17.9
|
)%
|
|
|
(12.2
|
)%
|
|
|
32.2
|
%
|
|
|
(17.9
|
)%
|
|
|
71.8
|
%
|
|
|
9.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of new distributors-YTD 2019
(2)
|
|
|
1,963
|
|
|
|
63
|
|
|
|
34
|
|
|
|
444
|
|
|
|
523
|
|
|
|
4,214
|
|
|
|
5,278
|
|
# of new distributors-YTD 2018
(2)
|
|
|
1,957
|
|
|
|
78
|
|
|
|
58
|
|
|
|
223
|
|
|
|
715
|
|
|
|
1,203
|
|
|
|
2,277
|
|
% change
|
|
|
0.3
|
%
|
|
|
(19.2
|
)%
|
|
|
(41.4
|
)%
|
|
|
99.1
|
%
|
|
|
(26.9
|
)%
|
|
|
250.3
|
%
|
|
|
131.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of new Master Affiliates-YTD 2019
|
|
|
264
|
|
|
|
3
|
|
|
|
2
|
|
|
|
22
|
|
|
|
33
|
|
|
|
217
|
|
|
|
277
|
|
# of new Master Affiliates-YTD 2018
|
|
|
184
|
|
|
|
6
|
|
|
|
10
|
|
|
|
25
|
|
|
|
61
|
|
|
|
81
|
|
|
|
183
|
|
% change
|
|
|
43.5
|
%
|
|
|
(50.0
|
)%
|
|
|
(80.0
|
)%
|
|
|
(12.0
|
)%
|
|
|
(45.9
|
)%
|
|
|
167.9
|
%
|
|
|
51.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# of Product orders-YTD 2019
|
|
|
50,658
|
|
|
|
1,891
|
|
|
|
1,116
|
|
|
|
2,075
|
|
|
|
5,746
|
|
|
|
21,175
|
|
|
|
32,003
|
|
# of Product orders-YTD 2018
|
|
|
52,729
|
|
|
|
2,297
|
|
|
|
1,235
|
|
|
|
1,638
|
|
|
|
6,954
|
|
|
|
13,666
|
|
|
|
25,790
|
|
% change
|
|
|
(3.9
|
)%
|
|
|
(17.7
|
)%
|
|
|
(9.6
|
)%
|
|
|
26.7
|
%
|
|
|
(17.4
|
)%
|
|
|
54.9
|
%
|
|
|
24.1
|
%
|
(1)
|
The new distributor totals for Q2 2019 and Q2 2018 include 1,569 and 943, respectively, of new worldwide preferred customers.
|
(2)
|
The new distributor totals for YTD 2019 and YTD 2018 include 4,064 and 1,725, respectively, of new worldwide preferred customers.
|
United States
|
●
|
Net sales in the United States declined by 6.8% in Q2 2019 compared to the prior-year quarter; however, new distributor and preferred customer enrollments increased by 8.4% in Q2 2019 compared to the prior-year quarter. New distributor enrollments have been improving since we reduced the enrollment fee for distributors from $40 to $20 in the United States in May 2019.
|
|
●
|
Products in the LunaRich line, including Reliv Now® and LunaRich X™, continued to perform well, constituting 14.9% and 11.9% of net sales in the United States, respectively, in Q2 2019. Reliv NOW and LunaRich X represented 16.0% and 12.3%, respectively, of net sales in the United States in the prior-year quarter.
|
|
●
|
New Master Affiliate qualifications increased by 47.6% and 43.5% in Q2 2019 and YTD 2019, respectively, in response to a cash bonus incentive in place beginning in Q1 2019.
|
|
●
|
Distributor retention was 77.8% for the twelve month period ended June 30, 2019 compared to 73.5% for all of 2018. Distributor retention is determined by the percentage of active distributors from 2018 that renewed their distributorships in 2019.
|
|
●
|
Our average order size in Q2 2019 increased by 1.0% to $318 at suggested retail value compared to the prior-year quarter. However, the number of product orders decreased by 4.6% in Q2 2019 compared to the prior year quarter.
|
|
●
|
In March 2019, we introduced a feature in our compensation plan in the United States to pay the wholesale profit earned by distributors on a weekly basis. This does not alter the timing of the expense recognition of the commission earnings, but does speed up the timing of the payment.
|
|
●
|
In January 2019, we sold substantially all of the machinery, equipment, inventory, tools and other assets and materials used in our manufacturing operations to Nutracom. Nutracom is substantially owned and is controlled by former officers/employees. Nutracom is leasing the manufacturing space in our facility for a period of seven years, with an option to renew for a five-year term. We also entered into agreements whereby Nutracom will continue to manufacture our core products on our premises for a period of seven years.
|
|
●
|
In late June 2019, we introduced our RLV line of hemp-extract products. Initially, the RLV line includes three liquid tinctures and one balm. All of the RLV products are derived from organically-grown, non-GMO hemp.
|
International Operations
|
●
|
The average foreign exchange rate for the U.S. dollar for YTD 2019 was stronger against all of the currencies in which we conduct business.
|
|
●
|
Australia/New Zealand and Canadian net sales in Q2 2019 decreased by 20.0% and 10.4%, respectively, in local currency compared to the prior-year quarter as the result of decreased distributor activity in the market.
|
|
●
|
Net sales in Mexico increased by 34.5% in local currency in Q2 2019 compared to the prior-year quarter. Distributor activity has increased in recent quarters subsequent to retaining a sales consultant with prior experience in network marketing sales in Mexico. New distributor enrollments increased by 37.9% in Q2 2019 compared to the prior-year quarter. Product order count increased by 24.0% in Q2 2019 as well.
|
|
●
|
Net sales in Europe decreased by 22.4% in local currency in Q2 2019 compared to the prior-year quarter. Distributor activity continues to decline both in the form of new distributor and preferred customer enrollments and number of product orders placed in the region.
|
|
●
|
Sales in Asia increased by 81.8% in local currency in Q2 2019 compared to the prior-year quarter, driven primarily by sales growth in the Philippines, our largest market in the region. All measures of distributor and preferred customer activity have grown rapidly. New distributor and preferred customer enrollments grew to 1,719 in Q2 2019 compared to 664 in the prior-year quarter. The number of new Master Affiliate qualifications grew to 118 in Q2 2019 compared to 27 in the prior year quarter and the product order count grew by 47.8% in Q2 2019.
|
Costs and Expenses
The following table sets forth selected results of our operations expressed as a percentage of net sales for the three- and six-month periods ended June 30, 2019 and 2018. Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods.
Income statement data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(amounts in thousands)
|
|
Three months ended
|
|
|
June 30, 2019
|
|
June 30, 2018
|
|
|
Amount
|
|
% of net sales
|
|
Amount
|
|
% of net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
8,257
|
|
|
|
100.0
|
%
|
|
$
|
8,460
|
|
|
|
100.0
|
%
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
2,269
|
|
|
|
27.5
|
|
|
|
2,356
|
|
|
|
27.9
|
|
Distributor royalties and commissions
|
|
|
2,665
|
|
|
|
32.3
|
|
|
|
2,827
|
|
|
|
33.4
|
|
Selling, general and administrative
|
|
|
3,689
|
|
|
|
44.6
|
|
|
|
4,216
|
|
|
|
49.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(366
|
)
|
|
|
(4.4
|
)
|
|
|
(939
|
)
|
|
|
(11.1
|
)
|
Interest income
|
|
|
46
|
|
|
|
0.5
|
|
|
|
23
|
|
|
|
0.3
|
|
Interest expense
|
|
|
(10
|
)
|
|
|
(0.1
|
)
|
|
|
(45
|
)
|
|
|
(0.6
|
)
|
Other income
|
|
|
5
|
|
|
|
0.1
|
|
|
|
7
|
|
|
|
0.1
|
|
Gain (loss) on sale of fixed assets
|
|
|
-
|
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(325
|
)
|
|
|
(3.9
|
)
|
|
|
(955
|
)
|
|
|
(11.3
|
)
|
Provision for income taxes
|
|
|
63
|
|
|
|
0.8
|
|
|
|
23
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(388
|
)
|
|
|
(4.7
|
)%
|
|
$
|
(978
|
)
|
|
|
(11.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per common share-Basic and Diluted
|
|
$
|
(0.22
|
)
|
|
|
|
|
|
$
|
(0.53
|
)
|
|
|
|
|
|
|
Six months ended
|
|
|
June 30, 2019
|
|
June 30, 2018
|
|
|
Amount
|
|
% of net sales
|
|
Amount
|
|
% of net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
17,747
|
|
|
|
100.0
|
%
|
|
$
|
18,463
|
|
|
|
100.0
|
%
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
4,703
|
|
|
|
26.5
|
|
|
|
4,706
|
|
|
|
25.5
|
|
Distributor royalties and commissions
|
|
|
5,783
|
|
|
|
32.6
|
|
|
|
6,219
|
|
|
|
33.7
|
|
Selling, general and administrative
|
|
|
7,428
|
|
|
|
41.8
|
|
|
|
8,702
|
|
|
|
47.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(167
|
)
|
|
|
(0.9
|
)
|
|
|
(1,164
|
)
|
|
|
(6.3
|
)
|
Interest income
|
|
|
95
|
|
|
|
0.5
|
|
|
|
48
|
|
|
|
0.3
|
|
Interest expense
|
|
|
(15
|
)
|
|
|
(0.1
|
)
|
|
|
(77
|
)
|
|
|
(0.5
|
)
|
Other income (loss)
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
17
|
|
|
|
0.1
|
|
Gain (loss) on sale of fixed assets
|
|
|
435
|
|
|
|
2.4
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
347
|
|
|
|
1.9
|
|
|
|
(1,176
|
)
|
|
|
(6.4
|
)
|
Provision for income taxes
|
|
|
111
|
|
|
|
0.6
|
|
|
|
40
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
236
|
|
|
|
1.3
|
%
|
|
$
|
(1,216
|
)
|
|
|
(6.6
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share- Basic and Diluted
|
|
$
|
0.13
|
|
|
|
|
|
|
$
|
(0.66
|
)
|
|
|
|
|
Cost of
Goods
Sold:
|
●
|
The cost of goods sold as a percentage of net sales in Q2 2019 decreased by 0.4% compared to the prior-year period and increased by 1.0% in YTD 2019 versus the prior-year YTD basis. The cost of goods sold as a percentage of net sales in Q2 2018 was negatively impacted by manufacturing expenses and plant utilization issues that no longer exist subsequent to our transaction with Nutracom. However, for YTD 2019 the cost of goods as a percentage continues to be negatively impacted by several factors, including promotions in the United States that reduced our freight income and the cost of sales associated with the leasing income now included in net sales subsequent to the adoption of ASU 2016-02.
|
Distributor Royalties and Commissions:
|
●
|
Distributor royalties and commissions as a percentage of net sales for Q2 2019 and YTD 2019 decreased by 1.1% of net sales when compared to the prior-year period. This decrease is due to the inclusion of leasing revenue in current year net sales on which distributor commissions are not paid.
|
Selling, General and Administrative Expenses:
|
●
|
Selling, general and administrative (“SGA”) expenses declined by $527,000 and by $1.3 million in Q2 2019 and YTD 2019, respectively, compared to the prior-year periods.
|
|
●
|
SGA expenses, including salaries and other staffing expenses, related to the manufacturing/Nutracom operations represent a net decrease of $624,000 of the SGA decrease in YTD 2019, compared to the prior-year period.
|
|
●
|
Other SGA salaries, other staffing expenses, benefits, and incentive compensation decreased in the aggregate by $276,000 in YTD 2019, compared to the prior-year period.
|
|
●
|
Sales and marketing expenses decreased by $266,000 in YTD 2019 compared to the prior-year period. Components of the decrease include:
|
|
○
|
$164,000 decrease in promotions expense, as we did not sponsor an incentive trip in the United States in YTD 2019 in contrast to the prior-year period.
|
|
○
|
$22,000 decrease in distributor conferences and meeting expenses.
|
|
○
|
$80,000 decrease in development and other sales expenses.
|
|
●
|
Other general and administrative expenses decreased by $73,000 in YTD 2019 versus the prior-year period.
|
Other Income/Expense:
|
●
|
The other income/expense in YTD 2019 and 2018 is primarily the result of foreign currency exchange gains (losses) on intercompany debt denominated in U.S. dollars in certain of our subsidiaries.
|
|
●
|
YTD 2019 includes $435,000 in income from the sale of our manufacturing equipment as part of the asset sale with Nutracom during Q1.
|
Income Taxes
:
|
●
|
We reported an income tax expense of $111,000 for YTD 2019 related to income taxes on our earnings in our Philippine entity and minimum U.S. state income tax expense.
|
|
●
|
See Note 8 of the Condensed Consolidated Financial Statements for additional detail regarding income taxes.
|
Net Income
:
|
●
|
We reported a net loss of $388,000 in Q2 2019 compared to a net loss of $978,000 in the prior-year quarter and net income of $236,000 in YTD 2019 compared to a net loss of $1.2 million in YTD 2018. On a YTD basis, the improvement in 2019 is primarily the result of the decrease in SGA expenses, coupled with the gain on the sale of fixed assets as part of the asset sale with Nutracom.
|
Liquidity and Capital Resources
During the first six months of 2019, we used $644,000 of net cash in operating activities, $60,000 was provided by investing activities, and $500,000 was provided by financing activities. This compares to $256,000 of net cash used in operating activities, $4,000 provided by investing activities, and $190,000 used in financing activities in the same period of 2018. Cash and cash equivalents decreased by $71,000 to $1.92 million as of June 30, 2019 compared to December 31, 2018.
Significant changes in working capital items consisted of an increase of $715,000 in accounts/notes receivable and deposits, a decrease in inventory of $759,000, an increase in prepaid expenses/other current assets of $296,000, and a decrease of $293,000 in accounts payable and other accrued expenses in the first six months of 2019. The increase in accounts/notes receivable and deposits is primarily the result of deposits required on production purchase orders to Nutracom, in accordance with the supply agreement executed as of January 1, 2019. The decrease in inventory is the result of the timing of the transfer of finished goods from Nutracom to us under the terms of the supply agreement, partially offset by cash payments for finished goods. The increase in prepaid expenses/other current assets primarily represents the annual premium payments made in the first quarter of 2019 on most of the corporate business insurance policies, and the decrease in accounts payable and other accrued expenses is primarily the result of a reduction in payables related to production in light of the supply agreement with Nutracom.
Investing activities during the first six months of 2019 consisted of a net investment of $50,000 for capital expenditures, offset by payments received on notes receivable with related parties of $110,000. Financing activities during the first six months of 2019 consisted of $500,000 in proceeds from line of credit borrowings.
Stockholders’ equity decreased to $11.74 million at June 30, 2019 compared to $11.99 million at December 31, 2018. The decrease is primarily due to the treasury stock of $540,000 acquired under the purchase agreement with Nutracom; offset by our net income during the first six months of 2019 of $236,000. Our working capital balance was $2.22 million at June 30, 2019 compared to $4.17 million at December 31, 2018. The current ratio at June 30, 2019 was 1.50 compared to 2.07 at December 31, 2018.
In September 2018, the maximum borrowing amount on our revolving line of credit was reduced from $2.0 million to $750,000. As amended, the revolver’s maturity date remained April 29, 2019 and the revolver’s interest rate continued to be based on the 30-day LIBOR plus 2.25%. As of June 30, 2019, we have borrowed $500,000 under our revolving line of credit. In March 2019, the revolving line of credit’s maturity date was extended to April 28, 2020, and the interest rate was revised to the 30-day LIBOR plus 3.00%. As amended, the revolver’s maximum borrowing amount remains $750,000. Borrowings under the lending agreement continue to be secured by all our tangible and intangible assets and by a mortgage on the real estate of our corporate headquarters.
We have experienced significant losses over the last several years and may experience a loss in 2019. Our existing cash, cash equivalents, operating revenue and borrowing facilities may not be sufficient to fund our operating expenses through the next 12 months which would require us to obtain additional financing before that time. We have taken several steps which management believes will result in an improved financial position, operating results, and cash flows. Over the last several years, we have also taken other cost cutting measures including reductions in staff, freezing or lowering salaries, limiting promotional events all in an effort to reduce operating expenses.
As detailed in Note 2 of the accompanying consolidated financial statements, in January 2019, we entered into a Purchase Agreement with Nutracom, LLC (Nutracom) pursuant to which Nutracom purchased the assets used by us in our manufacturing operations. Assets purchased by Nutracom from us were financed by us under payment terms scheduled to provide incoming funds to us of $100,000 or more per year. We have also entered into an agreement for Nutracom to lease a significant portion of our headquarters building. Management believes that these transactions with Nutracom will be favorable to our financial position, operating results, and cash flows; however, there are risks and uncertainties which arise with these Nutracom transactions and their impact to our operations.
Should the aforementioned changes to the company’s operations not provide sufficient cash flow improvement or should we be unable to obtain sufficient additional capital or borrowings, we may have to engage in any or all of the following activities: (i) monetize our headquarters building via traditional bank lending or a sale and leaseback-type transaction; (ii) monetize a note receivable from a distributor; (iii) modify our distributor promotions, incentives, and other activities; (iv) cease operations in certain geographic regions, and (v) reduce employee compensation and benefits.
We may not be able to obtain sufficient additional funding through monetizing certain of our existing assets, sourcing additional borrowings, and issuing additional equity, or any other means, and if we are able to do so, these available sources of funds may not be on satisfactory terms. Our ability to raise additional capital in the equity markets, should we choose to do so, is dependent on a number of factors, including, but not limited to, the market demand for our common stock, which itself is subject to a number of business risks and uncertainties, as well as the uncertainty that we would be able to raise such additional capital at a price or on terms that are favorable to us.
These actions may have a material adverse impact on our ability to achieve certain of our planned objectives. Even if we are able to source additional funding, we may be forced to significantly reduce our operations if our operating performance does not improve. If we are unable to source additional funding, we may be forced to significantly reduce or shut down our operations. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effect on our assets or liabilities should we not be able to continue as a going concern.
Critical Accounting Policies
A summary of our critical accounting policies and estimates is presented in our 2018 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2019. Except for the required adoption of ASU No. 2016-02, our critical accounting policies remain unchanged as of June 30, 2019.
Item No. 4 - Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2019. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of June 30, 2019, to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the second quarter of 2019 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.
PART II – OTHER INFORMATION
Item No. 6
–
Exhibits
101
|
Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss), (iii) the Condensed Consolidated Statements of Cash Flows, (iv) Condensed Consolidated Statements of Stockholders’ Equity, and (v) the Notes to Condensed Consolidated Financial Statements.
|